News

By Marcia Frellick. Hair loss, reduced sex drive, and erectile dysfunction have joined a list of more familiar symptoms linked to long-term COVID-19 in patients who were not hospitalized, according to the findings of a large study. Anuradhaa Subramanian, PhD, of the Applied Health Research Institute of the…

The Medicines and Healthcare products Regulatory Agency (MHRA) authorizes the bivalent dose manufactured by Moderna. BY MEDICAL EDITORIAL STAFF. The United Kingdom has become the first country to approve a Covid-19 vaccine targeting not only the original strain but also the Omicron variant. The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the…

By Nina Cosdón. Neutralization of BA.4 and BA.5 was significantly reduced in people who were infected with an earlier strain of Omicron, even if they were also vaccinated. The Omicron COVID-19 variant continues to mutate, and its subvariants account for the majority of new infections. This week, the U.S. Centers for Disease Control and Prevention (CDC)…

By Kathleen Doheny. It might be a good time to stock up on at-home COVID-19 tests. Today, the FDA issued new guidance on at-home COVID testing. It still recommends repeating the test after a negative result, but also recommends that people who are asymptomatic but believe they have been exposed get tested three times…

— Recommends wearing a mask for 10 days and getting tested on day 5 or later. By Joyce Frieden Instead of quarantining if exposed to COVID-19, wear a high-quality mask for 10 days and get tested on day 5 or later, regardless of vaccination status, the CDC suggested…

Considerations by Paul Max: HIV treatment is so spectacularly effective that you may be surprised to learn that some people with HIV still have uncontrolled viral replication. We HIV specialists watch with frustration and sadness as they experience progressive immunodeficiency, complications of advanced HIV disease, hospitalizations, and HIV-related deaths. Furthermore, while they are viremic…

By Hester Phillips. Drawing on the lessons learned from the recent AIDS2022 conference, we've compiled a summary of successful ways to reduce HIV-related stigma and address its harmful effects. What's this story about? Successful ways to reduce HIV-related stigma and address its harmful effects. Why is this important? The…

Edith Magak - The proportion of HIV treatment clinics that screen for depression, anxiety, and post-traumatic stress disorder (PTSD) is 50%, 14%, and 12%, respectively, in many regions of the world, reported Dr. Angela Parcesepe of the University of North Carolina at the 24th International Conference on…

Edith Magak: “A key point when thinking about how to reduce AIDS-related mortality is recognizing that, while expanding antiretroviral therapy (ART) is absolutely necessary to decrease deaths, ART alone is not enough to achieve mortality reduction targets,” Dr. Laura Broyles of Global Health…

Liz Highleyman - A man in Southern California, nicknamed the 'City of Hope patient,' appears to be the latest person cured of HIV after receiving a stem cell transplant from a donor with a rare mutation, bringing the total to five, according to a presentation Monday at the 24th International Conference…

Laura López González: A two-month injection of the antiretroviral drug cabotegravir is the most effective way to prevent HIV the world has ever seen. Making it affordable will depend, in part, on how many generic manufacturers invest in producing it, and for that, the world must demonstrate the promise of the markets: millions of healthy people who will line up…

Kate Johnson MONTREAL — Long-acting injectable cabotegravir (CAB LA) continues to show superiority over daily oral tenofovir diphosphate plus emtricitabine (TDF-FTC) as pre-exposure prophylaxis (PrEP) for HIV, according to new data from two HIV Prevention Trial Network (HPTN) studies reported here at the International Society for HIV/AIDS Conference.

The ANDES study shows that the least expensive therapy is a “safe and well-tolerated” option. By Ed Susman MONTREAL — A two-drug combination using a generic formulation of the protease inhibitor darunavir/ritonavir plus lamivudine appeared to control HIV as well as the same combination with tenofovir added, according to the results of the ANDES trial…

Will mRNA vaccines accelerate discovery? By Gus Cairns. It’s been 13 years since RV144 became the only HIV vaccine to produce a (marginally) positive result in a large efficacy trial. And it’s been eight years since aidsmap.com said the vaccine’s results were “real, and it could be made to work better.”

By Gus Cairns The 24th International AIDS Conference (AIDS 2022) in Montreal heard on Friday that, for the first time, scientists have developed a sensitive genetic assay that can specifically find the small subset of 'reservoir' cells that harbor a silent HIV infection by using nanotechnology to detect their distinct genetic signature. “The holy…

By Krishen Samuel, Richard Angell, and Chamut Kifetew of the Terrence Higgins Trust at AIDS 2022. Photo by Matthew Hodson. According to findings presented at the 24th International AIDS Conference (AIDS 2022) this week, significant gaps remain when it comes to hearing about and understanding Undetectable = Untransmittable (U=U) for people living with HIV worldwide…